Benzinga | May 4, 2021 07:18AM EDT

Concert Pharmaceuticals Q1 EPS $(0.67) Beats $(0.69) Estimate, Sales $5.00K Down From $7.00K YoY

Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.69) by 2.9 percent. This is a 4.29 percent increase over losses of $(0.70) per share from the same period last year. The company reported $5.00 thousand in sales this quarter. This is a 28.57 percent decrease over sales of $7.00 thousand the same period last year.